Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia

被引：3
作者：
Al-Samkari, Hanny [1 ,2 ,9 ]
Jiang, Debbie [3 ,4 ]
Gernsheimer, Terry [3 ,4 ]
Liebman, Howard [5 ]
Lee, Susie [5 ]
Bernheisel, Chelsea
Wojdyla, Matthew [6 ]
Vredenburg, Michael [6 ]
Cuker, Adam [7 ,8 ]
机构：
[1] Massachusetts Gen Hosp, Div Hematol, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Univ Washington, Div Hematol, Seattle, WA USA
[4] Seattle Canc Care Alliance, Seattle, WA USA
[5] Univ Southern Calif, Keck Sch Med, Hematol, Los Angeles, CA USA
[6] Sobi Inc, Durham, NC USA
[7] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA
[8] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA
[9] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA
来源：
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | 2023年 / 7卷 / 03期
关键词：
avatrombopag; eltrombopag; immune thrombocytopenia; romiplostim; thrombopoietin receptor;
D O I：
10.1016/j.rpth.2023.100134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study
    Oladapo, Abiola
    Kolodny, Scott
    Vredenburg, Michael
    Swallow, Elyse
    Goldschmidt, Debbie
    Sarathy, Kirthana
    Lopez, Priscilla
    Maitland, Hillary
    Yee, John
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [32] Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial
    Mei, Heng
    Liu, Xiaofan
    Li, Yan
    Zhou, Hu
    Feng, Ying
    Gao, Guangxun
    Cheng, Peng
    Huang, Ruibin
    Yang, Linhua
    Hu, Jianda
    Hou, Ming
    Yao, Yazhou
    Liu, Li
    Wang, Yi
    Wu, Depei
    Shen, Xuliang
    Jin, Jie
    Luo, Jianmin
    Zeng, Yun
    Zhou, Xin
    Xia, Ruixiang
    Jiang, Zhongxing
    Bai, Yuansong
    Niu, Ting
    Yang, Renchi
    Hu, Yu
    ANNALS OF HEMATOLOGY, 2024, 103 (07) : 2273 - 2281
  • [33] Total remission of severe immune thrombocytopenia after short term treatment with romiplostim
    Vlachaki, Efthymia
    Papageorgiou, Vaia
    Klonizakis, Filippos
    Spandonidou, Maria
    Chisan, Sofia
    Vetsiou, Evaggelia
    Ioannidou, Elissavet
    HEMATOLOGY REPORTS, 2011, 3 (03) : 58 - 59
  • [34] Impact of Eltrombopag Therapy in Different Lines of Treatment on Response in Patients with Immune Thrombocytopenia
    Karismaz, Abdulkadir
    Cavdar, Vahit Can
    Serin, Istemi
    Eren, Rafet
    ISTANBUL MEDICAL JOURNAL, 2024, 25 (03): : 241 - 244
  • [35] Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia
    Jose Gonzalez-Lopez, Tomas
    Sanchez-Gonzalez, Blanca
    Pascual, Cristina
    Arefi, Maryam
    de Cabo, Erik
    Alonso, Arancha
    Martin-Salces, Monica
    Jimenez-Barcenas, Reyes
    Calbacho, Maria
    Galan, Pilar
    Barez, Abelardo
    Ramon Gonzalez-Porras, Jose
    PLATELETS, 2015, 26 (01) : 83 - 86
  • [36] Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside
    Molineux, Graham
    Newland, Adrian
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) : 9 - 20
  • [37] Remissions after long-term use of romiplostim for immune thrombocytopenia
    Marshall, Ariela L.
    Scarpone, Roberta
    De Greef, Melanie
    Bird, Robert
    Kuter, David J.
    HAEMATOLOGICA, 2016, 101 (12) : E476 - E478
  • [38] Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul
    Esma Evrim Dogan
    Esra Turan Erkek
    Tugrul Elverdi
    Sule Celik Kamaci
    Ugur Ciftci
    Naciye Demirel
    Demet Aydin
    Rafet Eren
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 327 - 332
  • [39] Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul
    Dogan, Esma Evrim
    Erkek, Esra Turan
    Elverdi, Tugrul
    Kamaci, Sule Celik
    Ciftci, Ugur
    Demirel, Naciye
    Aydin, Demet
    Eren, Rafet
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (02) : 327 - 332
  • [40] Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?
    Baysal, Mehmet
    Bas, Volkan
    Umit, Elif
    Kirkizlar, Hakki Onur
    Demir, Ahmet Muzaffer
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (01) : 38 - 42
12345